Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Jason Gass
Data Entry Specialist
Liver Research Institute
Overview
Research
More
Collaboration
(7)
Maria Fotinos
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Tausif Chowdhury
Mutual work: 1 Grant
Collaboration Details
Gustavo Cornejo
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
Geoffrey Block
Mutual work: 3 Grants
Collaboration Details
Kirsten Anderson
Mutual work: 3 Grants﹒3 Proposals
Collaboration Details
Page 1 of 2
Previous page
Next page
Grants
(3)
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency?associated Liver Disease With Metavir
Active
·
2023
·
$0 / $1.6M
·
External
undefined (CD)
clinical trial,
liver disease,
alpha-1 antitrypsin,
treatment,
safety
TRANSFORM: A 52-week, Randomized, Placebo-controlled, Double-blind, Adaptive Phase 2b/3 Trial of Setanaxib with a 52-week Extension Phase in Patients with Primary Biliary Cholangitis (PBC) and Elevate
Active
·
2023
·
$0 / $641.6K
·
External
undefined (CD)
clinical trial,
drug therapy,
liver disease,
biomarker,
immunology
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2b/3 Study to Evaluate the Efficacy and Safety of Saroglitazar Magnesium in Subjects with Primary Biliary Cholangitis
Active
·
2022
·
$0 / $258.5K
·
External
undefined (CD)
clinical trials,
liver disease,
drug efficacy,
safety evaluation,
therapeutic intervention